Maple Tree Consultants
Here’s what they say
We’re delighted to announce the release of Medical Cannabis & Epilepsy, the second publication in our Medical Cannabis Evidence Base series.
Available in both print and PDF, this essential guide brings together, for the first time, all the latest research, clinical trials, and real-world evidence on cannabis-based medicinal products (CBMPs) and their role in treating epilepsy. This comprehensive resource allows clinicians to review the evidence themselves, offering a clear, detailed exploration of how cannabinoids—particularly CBD—can impact epilepsy, with a strong focus on drug-resistant cases.
Written by Prof Mike Barnes, Hannah Deacon, and Varinder Kaur, this publication is designed to support healthcare professionals, patients, and regulators by providing everything they need to know about CBMPs and epilepsy in one place.
Tackling Key Challenges in Medical Cannabis Epilepsy Treatment
Medical Cannabis & Epilepsy provides in-depth analysis of the barriers faced by patients in accessing CBMPs within the UK’s regulatory framework. The guide highlights significant gaps in NHS access, the growing reliance on private clinics, and the financial strain families encounter when seeking cannabis-based treatments.
Real-world evidence also takes centre stage, offering critical insights that complement traditional clinical trials, particularly for patients who don’t respond to conventional anti-seizure medications.
A Thorough Evidence Review
With over 280 references to peer-reviewed literature, Medical Cannabis & Epilepsy provides a comprehensive review of nearly 100 clinical trials, real-world studies, and observational research, covering topics such as:
-
Epilepsy Overview: A detailed introduction to the types, causes, and symptoms of epilepsy.
-
Mechanisms of Action: How cannabinoids like CBD and THC modulate brain pathways to reduce seizures.
-
THC in Children: Evidence surrounding the use of THC in paediatric epilepsy cases.
-
Drug Interactions: Potential interactions between CBMPs and conventional epilepsy medications.
-
Real-World Data: How patient-reported outcomes are shaping the future of epilepsy treatment.
This publication is a must-read for clinicians, regulators, and families seeking a deeper understanding of the use of cannabis in epilepsy care.
Part of Our Medical Cannabis Evidence Base Series
Medical Cannabis & Epilepsy is the second release in Maple Tree’s growing series of evidence-based publications. Our first release, An Introduction to Medical Cannabis, serves as a foundational resource, providing a fully referenced guide to the science behind medical cannabis. It explores the history of cannabis in medicine, the endocannabinoid system, and the practical aspects of prescribing CBMPs.
The Medical Cannabis Evidence Base series is designed to bridge the knowledge gap among healthcare professionals, demystify cannabis-based treatments, and enhance accessibility for those interested in the therapeutic benefits of CBMPs. Each publication builds on the last, covering a range of conditions from epilepsy to pain and anxiety, giving clinicians the confidence to navigate this emerging field.
Order Your Copy Today
Medical Cannabis & Epilepsy is now available in print and PDF format for purchase on our website.
Whether you’re a healthcare professional looking for evidence-based guidance or a patient seeking more information, this publication provides the tools you need to better understand cannabis-based treatments for epilepsy.
